Feldmann M - Search Results

1

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, et al. Elliott MJ, et al. Among authors: feldmann m. Lancet. 1994 Oct 22;344(8930):1105-10. doi: 10.1016/s0140-6736(94)90628-9. Lancet. 1994. PMID: 7934491 Clinical Trial.

2

How does infliximab work in rheumatoid arthritis?

Maini RN, Feldmann M. Maini RN, et al. Among authors: feldmann m. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S22-8. doi: 10.1186/ar549. Epub 2002 Mar 27. Arthritis Res. 2002. PMID: 12110154 Free PMC article. Review.

3

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J, Woody JN. Elliot MJ, et al. Among authors: feldmann m. Arthritis Rheum. 2008 Feb;58(2 Suppl):S92-S101. doi: 10.1002/art.23362. Arthritis Rheum. 2008. PMID: 18240199 Free article.

4

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.

Feldmann M, Maini RN. Feldmann M, et al. Joint Bone Spine. 2002 Jan;69(1):12-8. doi: 10.1016/s1297-319x(01)00335-9. Joint Bone Spine. 2002. PMID: 11858351 Review.

5

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.

Chu CQ, Field M, Feldmann M, Maini RN. Chu CQ, et al. Among authors: feldmann m. Arthritis Rheum. 1991 Sep;34(9):1125-32. doi: 10.1002/art.1780340908. Arthritis Rheum. 1991. PMID: 1930331

6

Cells with dendritic morphology and bright interleukin-1 alpha staining circulate in the blood of patients with rheumatoid arthritis.

Barkley DE, Feldmann M, Maini RN. Barkley DE, et al. Among authors: feldmann m. Clin Exp Immunol. 1990 Apr;80(1):25-31. doi: 10.1111/j.1365-2249.1990.tb06436.x. Clin Exp Immunol. 1990. PMID: 1969779 Free PMC article.

7

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Brennan FM, et al. Among authors: feldmann m. Lancet. 1989 Jul 29;2(8657):244-7. doi: 10.1016/s0140-6736(89)90430-3. Lancet. 1989. PMID: 2569055

8

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M. Buchan G, et al. Among authors: feldmann m. Clin Exp Immunol. 1988 Sep;73(3):449-55. Clin Exp Immunol. 1988. PMID: 3264773 Free PMC article.

9

TNF alpha is an effective therapeutic target for rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. Feldmann M, et al. Ann N Y Acad Sci. 1995 Sep 7;766:272-8. doi: 10.1111/j.1749-6632.1995.tb26675.x. Ann N Y Acad Sci. 1995. PMID: 7486670 Review.

10

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.

Elliott MJ, Feldmann M, Maini RN. Elliott MJ, et al. Among authors: feldmann m. Int J Immunopharmacol. 1995 Feb;17(2):141-5. doi: 10.1016/0192-0561(94)00092-3. Int J Immunopharmacol. 1995. PMID: 7544768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters